Weekly CFO Sells Highlight

recent sells from company CFOs

Author's Avatar
Mar 17, 2018
Article's Main Image

According to GuruFocus Insider Data, the recent CFO sells were: Hewlett Packard Enterprise Co (HPE, Financial) and Nektar Therapeutics Inc. (NKTR, Financial).

Hewlett Packard Enterprise Co: EVP and CFO Timothy C. Stonesifer sold 161,858 shares

EVP and CFO Timothy C. Stonesifer sold 161,858 shares for $18.3 per share on Mar. 02. Since then, the stock price has increased by 2.68%. Hewlett Packard Enterprise Co has a market cap of $29.18 billion and its shares were traded around $18.79. The company has a P/E ratio of 20.00 and P/S ratio of 1.08. The trailing 12-month dividend yield of Hewlett Packard Enterprise Co stocks is 1.47%, while the forward dividend yield is 1.59%.

Hewlett Packard Enterprise announced its first-quarter results with revenue of $7.67 billion and gross profit of $2.18 billion, while the net income was $1.44 billion. The 2017 total revenue was $28.87 billion, a 5% decrease from 2016. The 2017 gross profit was $8.69 billion, an 11% decrease from the year prior. The 2017 net income was $344 million.

Director Margaret C Whitman sold 674,000 shares for $18.88 per share on Mar. 15. Since then, the stock price has decreased by 0.48%. President Intelligent Edge Keerti Melkote sold 87,113 shares for $18.87 per share on Mar. 15. Since then, the stock price has decreased by 0.42%. CSO Interim Pres Hybrid IT Philip Davis sold 16,405 shares for $18.51 per share on Feb. 27. Since then, the stock price has increased by 1.51%.

Nektar Therapeutics Inc.: SVP and CFO Gil M Labrucherie sold 3,477 shares

SVP and CFO Gil M Labrucherie sold 3,477 shares for $82.94 per share on Feb. 16. Since then, the stock price has increased by 24.19%. Nektar Therapeutics Inc. has a market cap of $16.58 billion and its shares were traded around $103.00. The company has a P/S ratio of 53.47. Over the past 5 years, Nektar Therapeutics Inc. had an annual average earnings growth of 15.00%.

Nektar Therapeutics announced its fourth-quarter results with revenue of $95.47 million and gross profit of $85.71 million, while the net loss was $33.83 million. The 2017 total revenue was $307.71 million, an 86% increase from 2016. The 2017 gross profit was $277.16 million, a 105% increase from the year prior. The 2017 net loss was $96.69 million.

President and CEO Howard W Robin sold 12,788 shares for $82.94 per share on Feb. 16. Since then, the stock price has increased by 24.19%. Director Christopher A Kuebler sold 40,000 shares for $97.6 per share on Mar. 07. Since then, the stock price has increased by 5.53%. SVP and COO John Nicholson sold 220,144 shares for $99.27 per share on Mar. 07. Since then, the stock price has increased by 3.76%.

Disclosure: none